Trial Profile
A retrospective study of exenatide vs basal insulin in patients with type-2-diabetes-mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Sep 2016 New trial record